---
figid: PMC4001531__JCI69611.f4
figtitle: Melanoma NOS1 expression promotes dysfunctional IFN signaling
organisms:
- Homo sapiens
pmcid: PMC4001531
filename: JCI69611.f4.jpg
figlink: /pmc/articles/PMC4001531/figure/F4/
number: F4
caption: (A) IFN signaling pathway according to IPA, which highlighted JAK1, JAK2,
  IFNA1, and IFNA2 downregulation in L-mels (green). (B) G-coupled receptor pathway
  according to IPA with receptor families. Gi-coupled receptors were upregulated in
  L-mels (red).
papertitle: Melanoma NOS1 expression promotes dysfunctional IFN signaling.
reftext: Qiuzhen Liu, et al. J Clin Invest. 2014 May 1;124(5):2147-2159.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9235719
figid_alias: PMC4001531__F4
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC4001531__F4
ndex: 3a561088-df09-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4001531__JCI69611.f4.html
  '@type': Dataset
  description: (A) IFN signaling pathway according to IPA, which highlighted JAK1,
    JAK2, IFNA1, and IFNA2 downregulation in L-mels (green). (B) G-coupled receptor
    pathway according to IPA with receptor families. Gi-coupled receptors were upregulated
    in L-mels (red).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IFNA1
  - IFN1@
  - IFNA2
  - IFNA17
  - IFNA4
  - IFNA5
  - IFNA6
  - IFNA7
  - IFNA8
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA21
  - RARA
  - RAB40B
  - RARB
  - RARG
  - JAK2
  - TYK2
  - JAK1
  - PTPN2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - NFKB1
  - PES1
  - BCL2
  - MED14
  - GAST
  - GALNS
  - PAGR1
  - BAX
  - BAK1
  - MXI1
  - IFIT1
  - IRF9
  - IRF1
  - PSMB8
  - IFIT3
  - GRK4
  - FYN
  - PITX2
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - GAD1
  - GAD2
  - GRK2
  - ALDH7A1
  - PDE2A
  - PDE9A
  - PDE10A
  - PDE11A
  - PDE1A
  - PDE1B
  - PDE1C
  - PDE3A
  - PDE3B
  - PDE4A
  - PDE4B
  - PDE4C
  - PDE4D
  - PDE6A
  - PDE6B
  - PDE6C
  - PDE7A
  - PDE7B
  - PDE8A
  - PDE8B
  - XYLT2
  - SOS1
  - SOS2
  - ATP8A2
  - APRT
  - MFAP1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - RAPGEF3
  - RAPGEF4
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - RAP1A
  - RASA1
  - KRAS
  - HRAS
  - NRAS
  - RGS6
  - GRP
  - LSM4
  - LGALSL
  - UCMA
  - RASGRP1
  - RASGRP2
  - RASGRP3
  - RASGRP4
  - SYNGAP1
  - SYNM
  - AKT1
  - AKT2
  - AKT3
  - RAF1
  - BRAF
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - MAP3K8
  - CROT
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - LAMTOR3
  - PITRM1
  - RELA
  - RELB
  - REL
  - NFKB2
  - EPHB2
  - MAPK1
  - MAPK3
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
  - Rheumatoid arthritis
---
